跳到正文

Topper James N 内部人交易：近期 SEC Form 4 交易

过去 18 个月，Topper James N（CIK 1341382）在 4 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-05-21）。

日期公司身份类型股数市值
2026-05-21Phathom Pharmaceuticals, Inc. (PHAT)董事买入24,122$0
2025-09-30MBX Biosciences, Inc. (MBX)10% 以上股东买入666,666$12.0M
2025-09-17NewAmsterdam Pharma Co N.V. (NAMS)董事买入660$15,642
2025-09-17HilleVax, Inc. (HLVX)10% 以上股东卖出8.5M$16.6M
2025-09-17HilleVax, Inc. (HLVX)10% 以上股东卖出17,199$33,538
2025-09-10NewAmsterdam Pharma Co N.V. (NAMS)董事买入1,260$31,487
2025-08-13NewAmsterdam Pharma Co N.V. (NAMS)董事买入471$11,295
2025-06-26NewAmsterdam Pharma Co N.V. (NAMS)董事买入2,520$46,444
2025-06-26NewAmsterdam Pharma Co N.V. (NAMS)董事买入1,260$23,008
2025-06-18NewAmsterdam Pharma Co N.V. (NAMS)董事买入8,584$167,388
2025-06-05Phathom Pharmaceuticals, Inc. (PHAT)董事买入10,500$0
2025-05-23Phathom Pharmaceuticals, Inc. (PHAT)董事买入3,780$14,591
2025-05-15Phathom Pharmaceuticals, Inc. (PHAT)董事买入1,120$3,539
2025-05-15Phathom Pharmaceuticals, Inc. (PHAT)董事买入6,300$20,916
2025-05-13Phathom Pharmaceuticals, Inc. (PHAT)董事买入33,376$106,469
2025-05-13Phathom Pharmaceuticals, Inc. (PHAT)董事买入2,226$8,058
2025-05-13Phathom Pharmaceuticals, Inc. (PHAT)董事买入12,601$38,307

来源：SEC Form 4 申报文件 · 截至 2026-05-21